Skip to content

Prospective in vitro an ex vivo obeservation-study of the coagulation status in patients with different pH-levels (acidosis/ alkalosis)

Prospective in vitro an ex vivo obeservation-study of the coagulation status in patients with different pH-levels (acidosis/ alkalosis) - PropHKoag

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033997
Enrollment
40
Registered
2025-03-27
Start date
2026-10-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coagulation unter DOAC therapy

Interventions

Group 1: Healthy adults: - We collect blood samples from healthy adults.? - These samples are transported to the laboratory and supplemented with therapeutic concentrations of direct oral anticoagulan

Sponsors

Universitätsklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: receted consent abnormality in standard lab-work drugs with influence on coagulation pregnancy myelodisplastic syndrom

Design outcomes

Primary

MeasureTime frame
Comparison of rotational thrombelstometry results at different ph levels.

Countries

Germany

Contacts

Public ContactGerrit Herpertz

Universitätsklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie

gerrit.herpertz@uni-oldenburg.de015141455427

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026